RecruitingNCT07006831

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population


Sponsor

Devyser Inc.

Enrollment

400 participants

Start Date

Nov 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cell free dna, kidney disease, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Scripps Health

San Diego, California, United States

University of California San Francisco

San Francisco, California, United States

Piedmont Healthcare

Atlanta, Georgia, United States

University of Maryland Baltimore

Baltimore, Maryland, United States

Brigham & Women's Hospital

Boston, Massachusetts, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07006831


Related Trials